Goodness Growth Holdings, Inc. GDNSF
We take great care to ensure that the data presented and summarized in this overview for Goodness Growth Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GDNSF
View allLatest Institutional Activity in GDNSF
Top Purchases
Top Sells
About GDNSF
Goodness Growth Holdings, Inc. operates as a physician-led cannabis company in the United States. The company cultivates cannabis in environmentally friendly greenhouses; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other Goodness Growth branded retail dispensaries, as well as third-party dispensaries. As of March 11, 2022, it operated 18 dispensaries, which included 2 in Maryland, 8 in Minnesota, 4 in New Mexico, and 4 in New York; and offered wholesale cannabis products through third-party companies in Arizona, Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
Insider Transactions at GDNSF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Chicago Atlantic Credit Opportunities, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,300,078
+49.98%
|
$0
$0.54 P/Share
|
|
May 31
2024
|
Joshua Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121,625
+37.3%
|
-
|
|
Jul 31
2023
|
Kyle Eugene Kingsley Executive Chairman |
BUY
Conversion of derivative security
|
Direct |
6,541,100
+50.0%
|
-
|
|
Dec 14
2022
|
Joshua Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,272
+44.44%
|
-
|
|
Dec 14
2022
|
J Michael Schroeder GENERAL COUNSEL & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
257,221
+41.9%
|
-
|
|
Dec 14
2022
|
Amber Holly Shimpa PRESIDENT & CORP. SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
267,510
+41.9%
|
-
|
|
Dec 14
2022
|
Judd Theodore Nordquist |
BUY
Grant, award, or other acquisition
|
Direct |
85,742
+41.9%
|
-
|
|
Dec 14
2022
|
Victor E. Mancebo |
BUY
Grant, award, or other acquisition
|
Direct |
85,742
+41.9%
|
-
|
|
Dec 14
2022
|
John Andrew Heller CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
308,665
+41.9%
|
-
|
|
Mar 15
2022
|
Kyle Eugene Kingsley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
262,708
+50.0%
|
-
|
|
Mar 15
2022
|
Amber Holly Shimpa PRESIDENT & CORP. SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
103,491
+50.0%
|
-
|
|
Mar 15
2022
|
Stephen Dahmer CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
99,511
+50.0%
|
-
|
|
Mar 15
2022
|
John Andrew Heller CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
119,413
+50.0%
|
-
|
|
Mar 15
2022
|
Christian Gonzales Ocasio CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
99,511
+50.0%
|
-
|
|
Mar 15
2022
|
Patrick Peters EVP OF RETAIL |
BUY
Grant, award, or other acquisition
|
Direct |
79,609
+50.0%
|
-
|
|
Mar 15
2022
|
Judd Theodore Nordquist |
BUY
Grant, award, or other acquisition
|
Direct |
33,170
+50.0%
|
-
|
|
Mar 15
2022
|
Chelsea A Grayson |
BUY
Grant, award, or other acquisition
|
Direct |
33,170
+50.0%
|
-
|
|
Mar 15
2022
|
Ross Michael Hussey |
BUY
Grant, award, or other acquisition
|
Direct |
33,170
+50.0%
|
-
|
|
Mar 15
2022
|
Victor E. Mancebo |
BUY
Grant, award, or other acquisition
|
Direct |
33,170
+50.0%
|
-
|
|
Mar 15
2022
|
Joshua Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,585
+50.0%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 122K shares |
|---|---|
| Conversion of derivative security | 6.54M shares |
| Open market or private purchase | 1.3M shares |